Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Clinical and Translational Science|May 31, 2021
Association of CYP3A5 polymorphisms and parathyroid hormone with blood level of tacrolimus in patients with end-stage renal diseaseRyota Tanaka, Yosuke Suzuki, Hiroshi Watanabe, et al.
Pharmaceutical Research|July 1, 2026
Impact of Febrile State on Vancomycin Clearance in Pediatric Patients: Insights From Population Pharmacokinetic ModelingRyota Tanaka, Ayato Sawaguchi, Tomoyuki Mizuno, et al.
Therapeutic Drug Monitoring|September 15, 2021
A Broad Range High-Throughput Assay for Lenvatinib Using Ultra-High Performance Liquid Chromatography Coupled to Tandem Mass Spectrometry With Clinical Application in Patients With Hepatocellular CarcinomaYoshio Sueshige, Ken Shiraiwa, Koichi Honda, et al.
World Journal of Oncology|November 22, 2021
Maximum Plasma Concentration of Lenvatinib Is Useful for Predicting Thrombocytopenia in Patients Treated for Hepatocellular CarcinomaMizuki Endo, Koichi Honda, Tomoko Saito, et al.
Clinical Pharmacology and Therapeutics|March 17, 2025
Impact of Cancer Cachexia Progression on OATP1B1 Transport Activity: Quantitative Analysis Using Coproporphyrin-I as an Endogenous BiomarkerTakahiro Sumimoto, Ryota Tanaka, Yosuke Suzuki, et al.
European Journal of Clinical Pharmacology|June 19, 2026
Candidate-gene-based study of CYP3A-related single-nucleotide polymorphisms using 4β-hydroxycholesterol/cholesterol ratio as biomarker in a Japanese cohortRyota Tanaka, Yosuke Suzuki, Teruhide Koyama, et al.
Clinical and Translational Science|March 11, 2024
Evaluation of the usefulness of plasma 4β-hydroxycholesterol concentration normalized by 4α-hydroxycholesterol for accurate CYP3A phenotypingAyako Oda, Yosuke Suzuki, Haruki Sato, et al.
Pageof 6